BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
Queensland Health
Boehringer Ingelheim
Daiichi Sankyo
Cipla
Julphar
Mallinckrodt
Covington

Generated: January 19, 2018

DrugPatentWatch Database Preview

Luitpold Company Profile

« Back to Dashboard

Summary for Luitpold
International Patents:56
US Patents:4
Tradenames:76
Ingredients:73
NDAs:95

Drugs and US Patents for Luitpold

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold VERAPAMIL HYDROCHLORIDE verapamil hydrochloride INJECTABLE;INJECTION 070617-001 Nov 12, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 077387-001 Dec 26, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070820-001 Feb 11, 1987 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 091274-001 Sep 22, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 090920-001 Jan 19, 2010 AO RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090240-001 Jan 11, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 091104-001 Oct 8, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold AMINOPHYLLINE aminophylline INJECTABLE;INJECTION 087600-001 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold TORSEMIDE torsemide INJECTABLE;INJECTION 090656-002 Apr 21, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold Pharms Inc NANDROLONE DECANOATE nandrolone decanoate INJECTABLE;INJECTION 091252-001 Aug 30, 2010 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Luitpold

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,431,549 Methods and compositions for administration of iron ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Luitpold Drugs

Supplementary Protection Certificates for Luitpold Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2004 Austria ➤ Subscribe PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211
C/GB02/027 United Kingdom ➤ Subscribe PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425
C0002 France ➤ Subscribe PRODUCT NAME: MANNITOL; NAT. REGISTRATION NO/DATE: NL 34557 20080819; FIRST REGISTRATION: SE - 22708 20061020
C0002 Belgium ➤ Subscribe PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
C0022 France ➤ Subscribe PRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211
1214076/01 Switzerland ➤ Subscribe PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
C/GB98/030 United Kingdom ➤ Subscribe PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204
C0037 Belgium ➤ Subscribe PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
2006 00038 Denmark ➤ Subscribe PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
C0033 France ➤ Subscribe PRODUCT NAME: ALISKIRENE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE E CELUI-CI, AMLODIPINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, ET HYDROCHLOROTHIAZIDE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/11/730/001 20111122; FIRST REGISTRATION: 6167801 20110705
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
McKesson
Dow
Julphar
Cantor Fitzgerald
Queensland Health
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot